Search

Robert Jenkins

Examiner (ID: 15672)

Most Active Art Unit
2402
Art Unit(s)
1726, 3405, 2899, 1302, 2402
Total Applications
1932
Issued Applications
1833
Pending Applications
19
Abandoned Applications
80

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13777781 [patent_doc_number] => 20190002429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => Derivatives of Xanthone Compounds [patent_app_type] => utility [patent_app_number] => 15/934253 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934253 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/934253
Derivatives of Xanthone Compounds Mar 22, 2018 Abandoned
Array ( [id] => 15191307 [patent_doc_number] => 10493124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-03 [patent_title] => Angiotensin II alone or in combination for the treatment of hypotension [patent_app_type] => utility [patent_app_number] => 15/909617 [patent_app_country] => US [patent_app_date] => 2018-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10289 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15909617 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/909617
Angiotensin II alone or in combination for the treatment of hypotension Feb 28, 2018 Issued
Array ( [id] => 12884851 [patent_doc_number] => 20180186792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => HETEROBIFUNCTIONAL LINKERS WITH POLYETHYLENE GLYCOL SEGMENTS AND IMMUNE RESPONSE MODIFIER CONJUGATES MADE THEREFROM [patent_app_type] => utility [patent_app_number] => 15/905367 [patent_app_country] => US [patent_app_date] => 2018-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16331 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905367 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/905367
Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom Feb 25, 2018 Issued
Array ( [id] => 16041137 [patent_doc_number] => 10682419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-16 [patent_title] => Prodrugs of peptide epoxy ketone protease inhibitors [patent_app_type] => utility [patent_app_number] => 15/881919 [patent_app_country] => US [patent_app_date] => 2018-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 46 [patent_no_of_words] => 49362 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 421 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15881919 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/881919
Prodrugs of peptide epoxy ketone protease inhibitors Jan 28, 2018 Issued
Array ( [id] => 12786367 [patent_doc_number] => 20180153958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => CYCLIC DEPSIPEPTIDE COMPOUNDS AND THEIR USES [patent_app_type] => utility [patent_app_number] => 15/882510 [patent_app_country] => US [patent_app_date] => 2018-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15882510 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/882510
CYCLIC DEPSIPEPTIDE COMPOUNDS AND THEIR USES Jan 28, 2018 Abandoned
Array ( [id] => 13328509 [patent_doc_number] => 20180215792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => TWO-DIMENSIONAL STRUCTURES FROM PEPTOID OLIGOMERS AND METHODS OF MAKING [patent_app_type] => utility [patent_app_number] => 15/880768 [patent_app_country] => US [patent_app_date] => 2018-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4924 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15880768 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/880768
TWO-DIMENSIONAL STRUCTURES FROM PEPTOID OLIGOMERS AND METHODS OF MAKING Jan 25, 2018 Abandoned
Array ( [id] => 12808861 [patent_doc_number] => 20180161457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-14 [patent_title] => DISULFIDE-LINKED POLYETHYLENEGLYCOL/PEPTIDE CONJUGATES FOR THE TRANSFECTION OF NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 15/874338 [patent_app_country] => US [patent_app_date] => 2018-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37673 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15874338 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/874338
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids Jan 17, 2018 Issued
Array ( [id] => 12706909 [patent_doc_number] => 20180127469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => SUBSTITUTED UREA DEPSIPEPTIDE ANALOGS AS ACTIVATORS OF THE CLPP ENDOPEPTIDASE [patent_app_type] => utility [patent_app_number] => 15/863673 [patent_app_country] => US [patent_app_date] => 2018-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 442 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15863673 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/863673
Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase Jan 4, 2018 Issued
Array ( [id] => 13300233 [patent_doc_number] => 20180201653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => POLYPEPTIDE COMPOUND AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/852288 [patent_app_country] => US [patent_app_date] => 2017-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8037 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15852288 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/852288
Polypeptide compound and preparation method and use thereof Dec 21, 2017 Issued
Array ( [id] => 12863137 [patent_doc_number] => 20180179553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => COMPOSITIONS AND METHODS FOR NUCLEIC ACID AND/OR PROTEIN PAYLOAD DELIVERY [patent_app_type] => utility [patent_app_number] => 15/842829 [patent_app_country] => US [patent_app_date] => 2017-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54980 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842829 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/842829
COMPOSITIONS AND METHODS FOR NUCLEIC ACID AND/OR PROTEIN PAYLOAD DELIVERY Dec 13, 2017 Abandoned
Array ( [id] => 12606603 [patent_doc_number] => 20180094031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED [patent_app_type] => utility [patent_app_number] => 15/831681 [patent_app_country] => US [patent_app_date] => 2017-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19415 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15831681 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/831681
CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED Dec 4, 2017 Abandoned
Array ( [id] => 12790690 [patent_doc_number] => 20180155399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => TFPI INHIBITORS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/815347 [patent_app_country] => US [patent_app_date] => 2017-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66626 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815347 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/815347
TFPI inhibitors and methods of use Nov 15, 2017 Issued
Array ( [id] => 12233174 [patent_doc_number] => 20180066032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS' [patent_app_type] => utility [patent_app_number] => 15/815644 [patent_app_country] => US [patent_app_date] => 2017-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 106128 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815644 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/815644
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS Nov 15, 2017 Abandoned
Array ( [id] => 15225001 [patent_doc_number] => 10500204 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Vitamin receptor drug delivery conjugates for treating inflammation [patent_app_type] => utility [patent_app_number] => 15/811600 [patent_app_country] => US [patent_app_date] => 2017-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 81 [patent_figures_cnt] => 119 [patent_no_of_words] => 33915 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15811600 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/811600
Vitamin receptor drug delivery conjugates for treating inflammation Nov 12, 2017 Issued
Array ( [id] => 16230798 [patent_doc_number] => 10738338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-11 [patent_title] => Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate [patent_app_type] => utility [patent_app_number] => 15/782391 [patent_app_country] => US [patent_app_date] => 2017-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 13784 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782391 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/782391
Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate Oct 11, 2017 Issued
Array ( [id] => 14497913 [patent_doc_number] => 20190192611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => COMPOSITION FOR TREATING CELLULITE, AND MICRO-NEEDLE INCLUDING SAME [patent_app_type] => utility [patent_app_number] => 16/329553 [patent_app_country] => US [patent_app_date] => 2017-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329553 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/329553
Composition for treating cellulite, and microneedle including same Aug 28, 2017 Issued
Array ( [id] => 12158827 [patent_doc_number] => 20180030094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'CHEMICAL SYNTHESIS AND SCREENING OF BICYCLIC PEPTIDE LIBRARIES' [patent_app_type] => utility [patent_app_number] => 15/672617 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 38634 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672617 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/672617
Chemical synthesis and screening of bicyclic peptide libraries Aug 8, 2017 Issued
Array ( [id] => 12058621 [patent_doc_number] => 20170334965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'SFRP5-DERIVED PEPTIDE FRAGMENT AND COSMETIC COMPOSITION FOR SKIN WHITENING CONTAINING SAME' [patent_app_type] => utility [patent_app_number] => 15/664277 [patent_app_country] => US [patent_app_date] => 2017-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3790 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15664277 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/664277
SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same Jul 30, 2017 Issued
Array ( [id] => 12706900 [patent_doc_number] => 20180127466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => NMDA RECEPTOR MODULATORS AND PRODRUGS, SALTS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/658107 [patent_app_country] => US [patent_app_date] => 2017-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15658107 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/658107
NMDA receptor modulators and prodrugs, salts, and uses thereof Jul 23, 2017 Issued
Array ( [id] => 14452489 [patent_doc_number] => 10322191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Targeted conjugates and particles and formulations thereof [patent_app_type] => utility [patent_app_number] => 15/652957 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 42043 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652957 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/652957
Targeted conjugates and particles and formulations thereof Jul 17, 2017 Issued
Menu